Search research articles
Contact Us
Filters
Showing results (111-120 of 166) with videos related to
Page
of 17
Sort By:
The Journal of Allergy and Clinical Immunology. Global
|
October 2, 2023
Peanut, soy, and emerging legume allergy in Canada
Josie C E Cosyns, Tara Lynn M Frykas, Hailey V Hildebrand, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
September 23, 2009
A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group
George H Yoo, James Moon, Michael Leblanc, et al.
The Laryngoscope
|
November 19, 2016
Outcomes of nonsurgical management of locally advanced carcinomas of the sinonasal cavity
Shamit Chopra, Dev P Kamdar, David S Cohen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 13, 2007
The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901
Janice K Ryu, Suzanne Swann, Francis LeVeque, et al.
Cancer
|
January 30, 2002
The effects of exogenous p53 overexpression on HPV-immortalized and carcinogen transformed oral keratinocytes
George H Yoo, James Washington, Jeffrey Oliver, et al.
Head & Neck
|
May 1, 2016
Pretreatment computed tomographic gross tumor volume as predictor of persistence of tracheostomy and percutaneous endoscopic gastrostomy tube in patients undergoing larynx preservation
Newton J Hurst, Lucio M Pereira, Michael M Dominello, et al.
Proteomics
|
February 27, 2010
Differential proteomic analysis of lymphatic, venous, and arterial endothelial cells extracted from bovine mesenteric vessels
Vicky P K H Nguyen, George Hanna, Natalie Rodrigues, et al.
Cancer
|
December 17, 2013
Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129
Canhua Xiao, Alexandra Hanlon, Qiang Zhang, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
November 29, 2024
Canadian Society of Allergy and Clinical Immunology position statement: panel testing for food allergies
Abdulrahman Al Ghamdi, Elissa M Abrams, Stuart Carr, et al.
Head & Neck
|
August 26, 2006
Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the head and neck
Nasfat J Shehadeh, John F Ensley, Omer Kucuk, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 166) with videos related to
Sort By:
Page
of 17
The Journal of Allergy and Clinical Immunology. Global
|
October 2, 2023
Peanut, soy, and emerging legume allergy in Canada
Josie C E Cosyns, Tara Lynn M Frykas, Hailey V Hildebrand, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
September 23, 2009
A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group
George H Yoo, James Moon, Michael Leblanc, et al.
The Laryngoscope
|
November 19, 2016
Outcomes of nonsurgical management of locally advanced carcinomas of the sinonasal cavity
Shamit Chopra, Dev P Kamdar, David S Cohen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 13, 2007
The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901
Janice K Ryu, Suzanne Swann, Francis LeVeque, et al.
Cancer
|
January 30, 2002
The effects of exogenous p53 overexpression on HPV-immortalized and carcinogen transformed oral keratinocytes
George H Yoo, James Washington, Jeffrey Oliver, et al.
Head & Neck
|
May 1, 2016
Pretreatment computed tomographic gross tumor volume as predictor of persistence of tracheostomy and percutaneous endoscopic gastrostomy tube in patients undergoing larynx preservation
Newton J Hurst, Lucio M Pereira, Michael M Dominello, et al.
Proteomics
|
February 27, 2010
Differential proteomic analysis of lymphatic, venous, and arterial endothelial cells extracted from bovine mesenteric vessels
Vicky P K H Nguyen, George Hanna, Natalie Rodrigues, et al.
Cancer
|
December 17, 2013
Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129
Canhua Xiao, Alexandra Hanlon, Qiang Zhang, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
November 29, 2024
Canadian Society of Allergy and Clinical Immunology position statement: panel testing for food allergies
Abdulrahman Al Ghamdi, Elissa M Abrams, Stuart Carr, et al.
Head & Neck
|
August 26, 2006
Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the head and neck
Nasfat J Shehadeh, John F Ensley, Omer Kucuk, et al.
Page
of 17